Thérèse Aurran
Impact in
- Genetics top 5%
- Chronic Lymphocytic Leukemia Research
- Pathology and Forensic Medicine top 10%
- Lymphoma Diagnosis and Treatment
Papers in
- Genetics 17
- Chronic Lymphocytic Leukemia Research 17
-
- Lymphoma Diagnosis and Treatment 11
- Co-authors
- Stéphane Leprêtre (10 shared papers)Sylvie Chevret (6 shared papers)Neil E. Caporaso (1 shared paper)Elizabeth Raveché (1 shared paper)Beatrice Mahé (6 shared papers)Andy C. Rawstron (1 shared paper)Robert F. Vogt (1 shared paper)Paolo Ghia (1 shared paper)
In The Last Decade
Thérèse Aurran
18 papers receiving 262 citations
Peers
Comparison fields: 5 of 35
- Genetics 200
- Pathology and Forensic Medicine 153
- Hematology 36
- Immunology 66
- Oncology 36
Countries citing papers authored by Thérèse Aurran
This map shows the geographic impact of Thérèse Aurran's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thérèse Aurran with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thérèse Aurran more than expected).
Fields of papers citing papers by Thérèse Aurran
This network shows the impact of papers produced by Thérèse Aurran. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thérèse Aurran. The network helps show where Thérèse Aurran may publish in the future.
Co-authors
The 25 scholars most cited alongside Thérèse Aurran, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 68 | |
| 2 | 2007 | 54 | |
| 3 | 2019 | 49 | |
| 4 | 2016 | 23 | |
| 5 | 2021 | 22 | |
| 6 | 2006 | 10 | |
| 7 | 2011 | 7 | |
| 8 | 2009 | 7 | |
| 9 | 2017 | 7 | |
| 10 | 2016 | 5 | |
| 11 | 2016 | 4 | |
| 12 | 2024 | 2 | |
| 13 | 2014 | 2 | |
| 14 | 2010 | 2 | |
| 15 | 2016 | 2 | |
| 16 | 2013 | 2 | |
| 17 | 2011 | 1 | |
| 18 | 2007 | 1 | |
| 19 | 2025 | 0 |
About Thérèse Aurran
Thérèse Aurran is a scholar working on Genetics, Pathology and Forensic Medicine, Immunology, Public Health, Environmental and Occupational Health and Radiology, Nuclear Medicine and Imaging, having authored 19 papers that have together received 268 indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (17 papers), Lymphoma Diagnosis and Treatment (11 papers), Immunodeficiency and Autoimmune Disorders (4 papers), Acute Lymphoblastic Leukemia research (3 papers), Monoclonal and Polyclonal Antibodies Research (3 papers), Chronic Myeloid Leukemia Treatments (2 papers), Glycosylation and Glycoproteins Research (1 paper) and Galectins and Cancer Biology (1 paper). The work is most often cited by research in Genetics (200 citations), Pathology and Forensic Medicine (153 citations), Hematology (36 citations), Immunology (66 citations) and Oncology (36 citations). Thérèse Aurran has collaborated with scholars based in France, Belgium and Australia. Frequent co-authors include Stéphane Leprêtre, Sylvie Chevret, Neil E. Caporaso, Elizabeth Raveché, Beatrice Mahé, Andy C. Rawstron, Robert F. Vogt, Paolo Ghia, Véronique Leblond and Gerald E. Marti. Their work appears in journals such as Blood, British Journal of Haematology, Hematological Oncology, Open Heart and Bone Marrow Transplantation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.